Pregnancy and breastfeeding represent additional contraindications due to lack of safety data in these populations
Still, these findings are encouraging enough to warrant further research
Specific and manually curated databases for these functions, similar to MitoCarta, likely provide a more accurate set of relevant genes
Kidney Caution is advised in patients with kidney impairment, especially due to the presence of tranexamic acid, which may accumulate in severe kidney dysfunction
Mod GRF 1-29 triggers the natural release cascade at the pituitary level, while GHRP-2 amplifies this signal and inhibits somatostatin (a hormone that blocks growth hormone release)
Medical Considerations Low IGF-1 with symptoms of GH deficiency may warrant: GH stimulation testing Consideration of GH or peptide therapy under endocrinology or functional medicine guidance High IGF-1 may require: Acromegaly screening (IGF-1 + oral glucose tolerance GH suppression test) Adjustment of therapy dosages Cancer risk assessment and monitoring IGF-1, Longevity, and Health Span The relationship between IGF-1 and lifespan is U-shaped both extremes are associated with higher risk
